Antidepressants Flashcards
What are depressive episodes characterised by?
depressive mood, sadness severe enough to interfere with function
loss of interest or pleasure in daily activities (up to 2 weeks).
Sleep and appetite disturbances
Low energy levels, Decreased cognition
Aetiology of depression?
Unknown but involves genetic and environmental factors.
‣heredity, changes in neurotransmitter levels (decrease in
monoamines, serotonin & norepinephrine), altered
neuroendocrine function and psychosocial factors thought to play a
role
Drugs that induce depression?
- Beta-blockers (Atenolol)
- calcium channel blockers (Amlodipine)
- Benzodiazepines (Diazepam)
- Dopaminergic agents (Levodopa, α-methyldopa)
- Corticosteroids (Methylprednisolone)
- Anabolic steroids (Testosterone)
Depression treatment?
- Psychotherapy +
- Pharmacotherapy
tricyclic antidepressants
selective serotonin reuptake
inhibitors (SSRIs)
Serotonin-norepinephrine
reuptake inhibitors (SNRIs)
5-HT2antagonists
monoamine oxidase
inhibitors (MAOIs)
atypical antidepressants
lithium
Selective Serotonin Reuptake Inhibitors (SSRIs) drugs?
FESC (FUSEK FEELINGS)
Fluxoxetine
Escitalopram
Sertraline
Paroxetine
Selective Serotonin Reuptake Inhibitors (SSRIs) MOA?
prevent the (presynaptic) reuptake of 5-HT→more 5-HT to
stimulate postsynaptic 5-HT1 receptors
SSRIs I?
major depression, anxiety disorders (PTSD, PD, OCD, PDD etc.)
Fluoxetine: 20 - 40 mg po od;
What is the risk of fluxetine in the elderly?
cardiovascular & suicide risk
in the elderly
SSRIs S/E?
BAD SSRI
Body weight increase
Anorexia(first few months)
Dizziness
Suicidal Thoughts
Serotonin Syndrome
Reproductive-Sexual Dysfunction
Insomnia
SSRI DI?
DI: do not use with MAOI; fluoxetine can inhibit cytochrome P-450
isoenzymes and thus the metabolism of certain β -blockers including
propranolol and metoprolol → hypotension, bradycardia
Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs) drugs?
Very Damned
Venlafaxine, desvenlafaxine, duloxetine
Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs) drugs MOA for selective SNRI?
prevent the (presynaptic) reuptake of 5-HT, NE and DA (weak)→more 5-HT and NE to stimulate postsynaptic 5-
HT and NE receptors.
Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs) drugs MOA for TCA?
prevents the (presynaptic) reuptake of 5-HT and NE by
neuronal membrane; may also downregulate β–adrenergic and 5-HT
receptors
Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs) drugs I?
major depression, anxiety disorders (PTSD, PD, OCD, PDD etc.
Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs) drugs A/E?
N, D, anxiety, restlessness, insomnia, sexual dysfunction, ↑BP,
↑HR, agitation, serotonin-withdrawal syndrome; TCAs [additional
antimuscarinic (dry mouth, constipation, urinary retention),
orthostatic hypotension due to peripheral α1-blockade]
Monoamine oxidase inhibitors drugs?
Takes Pride In Shanghai
Tranylcypromine, moclobemide, phenelzine
Monoamine oxidase inhibitors MOA?
MOA:Inhibit one or both forms of MAO and thus the oxidative
deamination of NA, DA and 5-HT→ ↑ cytosolic stores of the
neurotransmitters
Monoamine oxidase inhibitors I?
I:refractory or atypical depression when SSRIs, TCAs and
sometimes even electroconvulsive therapy is ineffective.
MAO Tranycypromine?
irreversible, non-selective (inhibit MAO-A
and MAO-B);
↑ dose (20 - 30 mg po bid) for depression refractory to
sequential trials of other antidepressants
Tranycypromine A/E?
HAHA
Hypertension(postural) crsis(tyramine)
Anxiety, Agitation, Anorexia
Hypotension
Anticholinergic
Tranycypromine DI?
cause hypertensive crisis if asympathomimetic drugor
food containing tyramine is ingested concurrently (cheese
reaction);do not use with other classes of antidepressants
→prolong and potentiate the effects of CNS depressants such
as alcohol, anaesthetics, sedative hypnotics; interact with
pethidine causing hyperpyrexia and hypotension
Tranycypromine withdrawl?
delirium, psychosis, confusion
Bupropion MOA?
MOA: inhibit the reuptake of NE and dopamine
Bupropion I?
I: Major depression, smoking cessation
AE: nausea, vomiting, headaches, activation, agitation,
hypertension, and insomnia.
(less sexual dysfunction than other antidepressant medications
Bupropion CI?
CI: risk for seizures, seizure disorder, history of anorexia or bulimia,
or using or withdrawing from alcohol or benzodiazepines
Bupropion DI?
DI: Bupropion is a substrate of CYP2B6 liver enzymes and is a
strong inhibitor of CYP2D6.
Bupropion S/E?
Increased of risk seizure
Mirtazapine MOA?
MOA: antagonizes adrenergic, 5-HT2-, 5-HT3-receptors → ↑ NE and
5-HT. In addition, mirtazapine has activity at histamine (H)
receptors.
*
Sedation, increased appetite, and weight gain can be
problematic, particularly at lower doses.
*
has ↓ risk for causing sexual dysfunction compared to SSRIs.
CI:pregnancy, lactation, <18 ,yrs of age, coadministration with
MAOIs or within 14 days of their use.
DI: a substrate of CYP3A4 and CYP2D6 liver enzymes; a weak
inhibitor of CYP1A2 and CYP3A4 enzymes.
Mirtazapine I?
I: Major depression
Mirtazapine A/E?
Weight gain
Sedation
Mirtazapine CI?
Pregnancy, lactation, coadminstration with MAOI’s
Mirtazapine DI?
DI: a substrate of CYP3A4 and CYP2D6 liver enzymes; a weak
inhibitor of CYP1A2 and CYP3A4 enzymes.
Trazodone MOA?
MOA: thought to block 5-HT reuptake, ↑ 5-HT neurotransmission,
and block 5-HT2- postsynaptic receptors.
Trazodone I?
I: Depression
Trazodone A/E?
AE: sedation, nausea, sexual dysfunction, and orthostatic
hypotension.
(has rarely been associated with priapism and QT prolongation)
Trazodone D/I?
DI: metabolized mainly by CYP3A4, whereas active metabolite m-
chlorophenylpiperazine (mCCP) is metabolized by CYP2D6.
Trazodone CI?
CI:alcohol or hypnotics intoxication, acute MI, children and
adolescents <18 yrs.
Nefazodone structure similiarity?
Structurally similar to trazodone
Nefazodone MOA?
MOA: similar to trazodone
Nefazodone I?
I: first line for treatment of depression
Nefazodone I?
AE: dry mouth, nausea, constipation, visual alterations, orthostatic
hypotension, and sedation. (The most severe adverse effect
associated with nefazodone is hepatic failure).
Nefazodone DI?
DI: highly protein bound and is an inhibitor of CYP3A4.
Bipolar disorder drug?
Lithium
Lithium P/K?
-Narrow TI
-Nephrogenic diabetes insipidious
-Nephritis
-Decreased Blood Pressure
-Tremor
TCA drugs?
CIA
Clomipromine
Imipramine
Amittryilne
TCA drugs uses?
Clomipromine-used in OCD
Imipramine-Eneursis
Amittryilne-neurolgia
TCA MAO?
Blocks SERT, NERT, Alpha-1 & Beta-1 and muscuranic receptors
TCA S/E?
Muscuranic S/E: Constipation, Blurred Vision
Alpha-receptors: Postural Hypertension
Histamine: Weight gain
TCA overdose?
Coma, Seizure, Cardiac Arrest and Arrthymias